The effect of intermittent atrial tachyarrhythmia on heart failure or death in cardiac resynchronization therapy with defibrillator versus implantable cardioverter-defibrillator patients: A MADIT-CRT substudy (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy)

Journal of the American College of Cardiology

Volumn 63, Issue 12, 2014, Pages 1190-1197

  Ruwald, Anne Christine ^a,b   Pietrasik, Grzegorz ^c   Goldenberg, Ilan ^a,d   Kutyifa, Valentina ^a,e   Daubert, James P ^f   Ruwald, Martin H ^a,b   Jons, Christian ^b   McNitt, Scott ^a   Wang, Paul ^g   Zareba, Wojciech ^a   Moss, Arthur J ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^c UNIVERSITY AT BUFFALO   (United States)

^d SHEBA MEDICAL CENTER   (Israel)

^e SEMMELWEIS UNIVERSITY   (Hungary)

^f DUKE UNIVERSITY MEDICAL CENTER   (United States)

^g STANFORD UNIVERSITY   (United States)

Author keywords

atrial arrhythmia; cardiac resynchronization therapy; death; efficacy; heart failure; implantable cardioverter defibrillator; left atrial volume; left bundle branch block; reverse remodeling

Indexed keywords

ADULT; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CARDIAC RESYNCHRONIZATION THERAPY DEVICE; CARDIOVASCULAR RESPONSE; CARDIOVASCULAR RISK; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CONTROLLED STUDY; DEATH; DEFIBRILLATOR; FEMALE; HEART FAILURE; HEART LEFT BUNDLE BRANCH BLOCK; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; QRS COMPLEX; RISK REDUCTION; TACHYCARDIA; TREATMENT RESPONSE; AGED; CARDIOVASCULAR EFFECT; CARDIOVASCULAR MORTALITY; DISEASE ASSOCIATION; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; INTERMITTENT ATRIAL TACHYARRHYTHMIA; MAJOR CLINICAL STUDY; MEDICAL HISTORY; MIDDLE AGED; MULTICENTER STUDY (TOPIC); OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT;

ATRIAL ARRHYTHMIA; CARDIAC RESYNCHRONIZATION THERAPY; DEATH; EFFICACY; HEART FAILURE; IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR; LEFT ATRIAL VOLUME; LEFT BUNDLE BRANCH BLOCK; REVERSE REMODELING;

AGED; BUNDLE-BRANCH BLOCK; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOMYOPATHIES; DEFIBRILLATORS; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; FEMALE; HEART ATRIA; HEART FAILURE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; TACHYCARDIA;

EID: 84896940614     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2013.10.074     Document Type: Article

References (27)

1. A.J. Moss, W.J. Hall, and D.S. Cannom et al. Cardiac-resynchronization therapy for the prevention of heart-failure events N Engl J Med 361 2009 1329 1338
2. A.S. Tang, G.A. Wells, and M. Talajic et al. Cardiac-resynchronization therapy for mild-to-moderate heart failure N Engl J Med 363 2010 2385 2395
3. J.G. Cleland, J.C. Daubert, and E. Erdmann et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure N Engl J Med 352 2005 1539 1549
4. M.R. Bristow, L.A. Saxon, and J. Boehmer et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure N Engl J Med 350 2004 2140 2150
5. W. Zareba, H. Klein, and I. Cygankiewicz et al. Effectiveness of cardiac resynchronization therapy by QRS morphology in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT) Circulation 123 2011 1061 1072
6. I. Sipahi, J.C. Chou, and M. Hyden et al. Effect of QRS morphology on clinical event reduction with cardiac resynchronization therapy: meta-analysis of randomized controlled trials Am Heart J 163 2012 260 267
7. J.J. McMurray, S. Adamopoulos, and S.D. Anker et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology Eur Heart J 33 2012 1787 1847
8. C.M. Tracy, A.E. Epstein, and D. Darbar et al. 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society J Am Coll Cardiol 61 2013 e6 e75
9. M. Gasparini, A. Auricchio, and F. Regoli et al. Four-year efficacy of cardiac resynchronization therapy on exercise tolerance and disease progression: the importance of performing atrioventricular junction ablation in patients with atrial fibrillation J Am Coll Cardiol 48 2006 734 743
10. J.S. Healey, S.H. Hohnloser, and D.V. Exner et al. Cardiac resynchronization therapy in patients with permanent atrial fibrillation: results from the Resynchronization for Ambulatory Heart Failure Trial (RAFT) Circ Heart Fail 5 2012 566 570
11. S.B. Wilton, A.A. Leung, W.A. Ghali, P. Faris, and D.V. Exner Outcomes of cardiac resynchronization therapy in patients with versus those without atrial fibrillation: a systematic review and meta-analysis Heart Rhythm 8 2011 1088 1094
12. A.M. Ferreira, P. Adragao, and D.M. Cavaco et al. Benefit of cardiac resynchronization therapy in atrial fibrillation patients vs. patients in sinus rhythm: the role of atrioventricular junction ablation Europace 10 2008 809 815
13. M. Gasparini, F. Regoli, P. Galimberti, C. Ceriotti, and A. Cappelleri Cardiac resynchronization therapy in heart failure patients with atrial fibrillation Europace 11 Suppl 5 2009 v82 v86
14. B.A. Koplan, A.J. Kaplan, and S. Weiner et al. Heart failure decompensation and all-cause mortality in relation to percent biventricular pacing in patients with heart failure: is a goal of 100% biventricular pacing necessary? J Am Coll Cardiol 53 2009 355 360
15. M. Gasparini, A. Auricchio, and M. Metra et al. Long-term survival in patients undergoing cardiac resynchronization therapy: the importance of performing atrio-ventricular junction ablation in patients with permanent atrial fibrillation Eur Heart J 29 2008 1644 1652
16. A.N. Ganesan, A.G. Brooks, and K.C. Roberts-Thomson et al. Role of AV nodal ablation in cardiac resynchronization in patients with coexistent atrial fibrillation and heart failure a systematic review J Am Coll Cardiol 59 2012 719 726
17. K. Dickstein, P.E. Vardas, and A. Auricchio et al. 2010 focused update of ESC guidelines on device therapy in heart failure: an update of the 2008 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy Eur Heart J 31 2010 2677 2687
18. A. Brenyo, M.S. Link, and A. Barsheshet et al. Cardiac resynchronization therapy reduces left atrial volume and the risk of AT in MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy) J Am Coll Cardiol 58 2011 1682 1689
19. C. Leclercq, L. Padeletti, and R. Cihak et al. Incidence of paroxysmal atrial tachycardias in patients treated with cardiac resynchronization therapy and continuously monitored by device diagnostics Europace 12 2010 71 77
20. C.J. Borleffs, C. Ypenburg, and R.J. van Bommel et al. Clinical importance of new-onset atrial fibrillation after cardiac resynchronization therapy Heart Rhythm 6 2009 305 310
21. A.J. Moss, M.W. Brown, and D.S. Cannom et al. Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT): design and clinical protocol Ann Noninvasive Electrocardiol 10 Suppl 2005 34 43
22. S.D. Solomon, E. Foster, and M. Bourgoun et al. Effect of cardiac resynchronization therapy on reverse remodeling and relation to outcome: Multicenter Automatic Defibrillator Implantation Trial: Cardiac Resynchronization Therapy Circulation 122 2010 985 992
23. M. Gasparini, P. Galimberti, and C. Ceriotti The importance of increased percentage of biventricular pacing to improve clinical outcomes in patients receiving cardiac resynchronization therapy Curr Opin Cardiol 28 2013 50 54
24. M. Santini, M. Gasparini, and M. Landolina et al. Device-detected atrial tachyarrhythmias predict adverse outcome in real-world patients with implantable biventricular defibrillators J Am Coll Cardiol 57 2011 167 172
25. E.J. Benjamin, P.A. Wolf, and R.B. D'Agostino et al. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study Circulation 98 1998 946 952
26. O.D. Pedersen, H. Bagger, L. Kober, and C. Torp-Pedersen The occurrence and prognostic significance of atrial fibrillation/-flutter following acute myocardial infarction. TRACE Study Group. Trandolapril Cardiac Evalution Eur Heart J 20 1999 748 754
27. P. Jabre, X. Jouven, and F. Adnet et al. Atrial fibrillation and death after myocardial infarction: a community study Circulation 123 2011 2094 2100